PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV · Clinician

Microdosing GLP1s. Is it safe? Mounjaro | Ozempic

Clinician13:03Jul 2025

Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The channel explains why microdosing GLP-1 medications such as Mounjaro is controversial among doctors. She notes there is no agreed definition: some people mean anything under the 2.5 mg minimum dose, others mean anything under 10 mg, and some count clicks on a 10 mg pen to take 5 mg. For the video she uses any dose below 2.5 mg. Her overarching rule is that people should not do with a GLP-1 what they would not do with medicines for other conditions.

Published by Dr Emma Anders on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

She lists four reasons people microdose: the lowest dose is too strong for them, they use the drugs for other purposes such as inflammation, mental health or addiction, they want to save money by stretching a pen, or they have only a little weight to lose. She says the main objection from doctors is the lack of evidence. That does not mean it fails to work, she says, only that the benefits and risks are unknown. Off-label prescribing is possible after a discussion with a clinician, but it adds risk. She also says lower doses do not always bring lower risk, citing antidepressants that have different effects at different doses, and that using the Mounjaro KwikPen outside its design bypasses safety features.

On cost, she says an opened pen should be discarded after 30 days because of bacteria introduced through the bung and possible degradation of the medicine, and that wiping with alcohol does not make it sterile. For people with 5 to 10 pounds to lose, she says dose does not predict weight loss, since she lost five stone on 2.5 mg. She says the real question is risk versus benefit, not dose, and that the evidence to answer it is not yet available.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:00 The speaker says microdosing has no agreed definition, and she uses any dose below 2.5 mg for the video.
  2. 2:32 She gives four reasons people microdose: dose too strong, other uses, saving money, and a small amount of weight to lose.
  3. 3:36 She says doctors object mainly because there is no evidence, which means the benefits and risks are unknown rather than proven absent.
  4. 7:42 She argues that using the pen in ways it was not designed for removes built-in safeguards, especially for vulnerable patients.
  5. 8:12 She explains that an opened pen should be thrown away after 30 days because of bacterial contamination and degradation, even if it is wiped with alcohol.
  6. 10:13 She says dose does not predict weight loss, and for people with little to lose the question is whether to take the drug at all.

Key moments

Tap one to play from there.

  1. 0:00 Intro
  2. 2:55 Why Microdosing
  3. 4:30 Offlabel prescribing
  4. 6:48 Microdosing advice
  5. 10:27 Risk vs benefit

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic and Mounjaro

Questions this video answers

What is microdosing GLP-1 medications?

According to the speaker, there is no official definition. Some people mean doses below the 2.5 mg minimum for Mounjaro, others mean anything below 10 mg, and some take part of a larger pen's dose by counting clicks. She uses doses under 2.5 mg in the video.

Why do some doctors object to microdosing GLP-1s?

She says the main reason is that there is no evidence supporting it, so the benefits and risks are unknown. She adds that this is not the same as saying it does not work, and that prescribing a non-standard dose is possible off-label after a discussion with a clinician.

How long can you use a Mounjaro pen after opening it?

The speaker says an opened pen should be disposed of after 30 days. She explains that a needle through the bung introduces bacteria and the medication may degrade, and that wiping with alcohol does not make the bung sterile.

Should people with only 5 to 10 pounds to lose microdose?

She says dose does not reliably match the amount of weight lost, noting she lost five stone on 2.5 mg while some people on 10 to 15 mg lost less. She says the real issue for this group is whether the risk versus benefit justifies taking the drug at all, and that the evidence is not available.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Microdosing GLP-1s: what it saves you, and what it doesn't

    Microdosing a GLP-1 does not save money at a compounded seller: none of the compounded programs we track charges less for a smaller dose. Microdosing is not a medical term, and no dose below the label's starting dose has been studied for this. The one microdosing product on our board costs more a month than full-dose compounded tirzepatide at the cheapest seller we track. Where dose really moves the price is the brands; the provider table, per-mg costs and live numbers are below.

  • GLP-1 dosage chart: every brand's starting dose, step-ups and top dose, straight from the FDA labels

    Every GLP-1 label starts low and climbs. The weekly shots start at 0.25 mg (Wegovy, Ozempic) or 2.5 mg (Zepbound, Mounjaro) and step up no faster than every 4 weeks, to a top dose of 7.2 mg, 2 mg or 15 mg. The daily pills climb in 30-day steps: Wegovy pill 1.5 to 25 mg, Ozempic pill 1.5 to 9 mg, Rybelsus 3 to 14 mg, Foundayo 0.8 to 17.2 mg. No label converts one drug's milligrams into another's.

  • Stopping a GLP-1: what the withdrawal trials found, and what a maintenance dose actually is

    Two trials have measured what happens when you stop. On semaglutide, people who lost 17.3% over 68 weeks regained two-thirds of it in the year after stopping, ending 5.6% below where they started. On tirzepatide, people who lost 20.9% in 36 weeks regained 14% over the next year on placebo while those who continued lost a further 5.5%. Both labels are explicit that these drugs are for maintaining weight reduction long term, which is a different claim from finishing a course. A maintenance dose is simply the dose you stay on; the labels do not define a lower one to step down to at goal.

Next steps

Ozempic prices

Insurance

Find more like it

Side effectsDose changeWeigh-in and resultsMood and mental healthInjection technique

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV